Imagin Medical Inc. (IMEXF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2022 | 14.68 Million CAD | 19.25% |
| 2021 | 12.31 Million CAD | 2138.56% |
| 2020 | 550.13 Thousand CAD | 43.87% |
| 2019 | 382.38 Thousand CAD | 112.99% |
| 2018 | 179.52 Thousand CAD | -80.07% |
| 2017 | 900.79 Thousand CAD | 299.55% |
| 2016 | 225.45 Thousand CAD | 3.66% |
| 2015 | 217.48 Thousand CAD | 193.24% |
| 2014 | 74.16 Thousand CAD | 39.37% |
| 2013 | 53.21 Thousand CAD | 3.55% |
| 2012 | 51.39 Thousand CAD | -89.44% |
| 2011 | 486.61 Thousand CAD | 218.53% |
| 2010 | 152.76 Thousand CAD | -80.26% |
| 2009 | 773.86 Thousand CAD | 418.64% |
| 2008 | 149.21 Thousand CAD | -91.87% |
| 2007 | 1.83 Million CAD | 409.59% |
| 2006 | 359.97 Thousand CAD | 797.52% |
| 2005 | 40.1 Thousand CAD | -80.04% |
| 2004 | 200.93 Thousand CAD | 49.99% |
| 2003 | 133.96 Thousand CAD | 107.37% |
| 2002 | 64.6 Thousand CAD | 174.07% |
| 2001 | 23.57 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q3 | 13.08 Million CAD | -14.6% |
| 2023 Q1 | 14.5 Million CAD | -1.2% |
| 2023 Q2 | 15.31 Million CAD | 5.57% |
| 2022 Q1 | 13.06 Million CAD | 6.08% |
| 2022 FY | 14.68 Million CAD | 19.25% |
| 2022 Q2 | 14.98 Million CAD | 14.69% |
| 2022 Q4 | 14.68 Million CAD | 56.48% |
| 2022 Q3 | 9.38 Million CAD | -37.36% |
| 2021 Q1 | 1.45 Million CAD | 164.03% |
| 2021 Q2 | 4.61 Million CAD | 217.93% |
| 2021 Q4 | 12.31 Million CAD | 161.14% |
| 2021 Q3 | 4.71 Million CAD | 2.12% |
| 2021 FY | 12.31 Million CAD | 2138.56% |
| 2020 Q1 | 373.36 Thousand CAD | -2.36% |
| 2020 Q3 | 152.37 Thousand CAD | -54.05% |
| 2020 Q4 | 550.13 Thousand CAD | 261.04% |
| 2020 FY | 550.13 Thousand CAD | 43.87% |
| 2020 Q2 | 331.63 Thousand CAD | -11.18% |
| 2019 Q2 | 192.88 Thousand CAD | 1.94% |
| 2019 FY | 382.38 Thousand CAD | 112.99% |
| 2019 Q1 | 189.21 Thousand CAD | 5.39% |
| 2019 Q3 | 254.94 Thousand CAD | 32.18% |
| 2019 Q4 | 382.38 Thousand CAD | 49.99% |
| 2018 Q2 | 69.65 Thousand CAD | -67.12% |
| 2018 Q4 | 179.52 Thousand CAD | 66.63% |
| 2018 FY | 179.52 Thousand CAD | -80.07% |
| 2018 Q1 | 211.81 Thousand CAD | -76.49% |
| 2018 Q3 | 107.73 Thousand CAD | 54.68% |
| 2017 Q3 | 707.95 Thousand CAD | 44.77% |
| 2017 FY | 900.79 Thousand CAD | 299.55% |
| 2017 Q1 | 247.19 Thousand CAD | 9.65% |
| 2017 Q2 | 489.01 Thousand CAD | 97.82% |
| 2017 Q4 | 900.79 Thousand CAD | 27.24% |
| 2016 Q3 | 73.58 Thousand CAD | -23.52% |
| 2016 FY | 225.45 Thousand CAD | 3.66% |
| 2016 Q4 | 225.45 Thousand CAD | 206.37% |
| 2016 Q2 | 96.21 Thousand CAD | -73.09% |
| 2016 Q1 | 357.56 Thousand CAD | 64.4% |
| 2015 FY | 217.48 Thousand CAD | 193.24% |
| 2015 Q4 | 217.48 Thousand CAD | 52.01% |
| 2015 Q3 | 143.07 Thousand CAD | 5.43% |
| 2015 Q2 | 135.7 Thousand CAD | 9.75% |
| 2015 Q1 | 123.65 Thousand CAD | 66.72% |
| 2014 Q3 | 21.34 Thousand CAD | -76.51% |
| 2014 FY | 74.16 Thousand CAD | 39.37% |
| 2014 Q4 | 74.16 Thousand CAD | 247.48% |
| 2014 Q1 | 41.52 Thousand CAD | -21.97% |
| 2014 Q2 | 90.85 Thousand CAD | 118.81% |
| 2013 Q3 | 14.01 Thousand CAD | -26.04% |
| 2013 Q2 | 18.94 Thousand CAD | -59.02% |
| 2013 Q4 | 53.21 Thousand CAD | 279.81% |
| 2013 FY | 53.21 Thousand CAD | 3.55% |
| 2013 Q1 | 46.22 Thousand CAD | -10.05% |
| 2012 Q1 | 44.1 Thousand CAD | -90.94% |
| 2012 Q3 | 103.22 Thousand CAD | 784.91% |
| 2012 Q4 | 51.39 Thousand CAD | -50.21% |
| 2012 FY | 51.39 Thousand CAD | -89.44% |
| 2012 Q2 | 11.66 Thousand CAD | -73.55% |
| 2011 Q2 | 32.49 Thousand CAD | -44.41% |
| 2011 Q3 | 304.64 Thousand CAD | 837.62% |
| 2011 Q4 | 486.61 Thousand CAD | 59.73% |
| 2011 FY | 486.61 Thousand CAD | 218.53% |
| 2011 Q1 | 58.44 Thousand CAD | -61.74% |
| 2010 Q1 | 649.17 Thousand CAD | -16.11% |
| 2010 FY | 152.76 Thousand CAD | -80.26% |
| 2010 Q4 | 152.76 Thousand CAD | 88.45% |
| 2010 Q3 | 81.06 Thousand CAD | -35.21% |
| 2010 Q2 | 125.12 Thousand CAD | -80.73% |
| 2009 FY | 773.86 Thousand CAD | 418.64% |
| 2009 Q4 | 773.86 Thousand CAD | 217.86% |
| 2009 Q3 | 243.46 Thousand CAD | 79.65% |
| 2009 Q2 | 135.52 Thousand CAD | 2.01% |
| 2009 Q1 | 132.85 Thousand CAD | -10.96% |
| 2008 Q2 | 809.82 Thousand CAD | -59.3% |
| 2008 Q4 | 149.21 Thousand CAD | -79.55% |
| 2008 Q3 | 729.52 Thousand CAD | -9.92% |
| 2008 FY | 149.21 Thousand CAD | -91.87% |
| 2008 Q1 | 1.98 Million CAD | 8.46% |
| 2007 Q3 | 98.35 Thousand CAD | -14.03% |
| 2007 Q4 | 1.83 Million CAD | 1765.19% |
| 2007 Q2 | 114.39 Thousand CAD | -81.87% |
| 2007 Q1 | 631.1 Thousand CAD | 75.32% |
| 2007 FY | 1.83 Million CAD | 409.59% |
| 2006 Q2 | 111.07 Thousand CAD | 171.55% |
| 2006 Q1 | 40.9 Thousand CAD | 1.99% |
| 2006 FY | 359.97 Thousand CAD | 797.52% |
| 2006 Q4 | 359.97 Thousand CAD | 33.41% |
| 2006 Q3 | 269.83 Thousand CAD | 142.93% |
| 2005 Q1 | 199.21 Thousand CAD | -0.86% |
| 2005 FY | 40.1 Thousand CAD | -80.04% |
| 2005 Q2 | 110.59 Thousand CAD | -44.48% |
| 2005 Q4 | 40.1 Thousand CAD | 133.09% |
| 2005 Q3 | 17.2 Thousand CAD | -84.44% |
| 2004 Q2 | 174.79 Thousand CAD | 13.49% |
| 2004 Q3 | 193.66 Thousand CAD | 10.8% |
| 2004 Q1 | 154.01 Thousand CAD | 14.97% |
| 2004 Q4 | 200.93 Thousand CAD | 3.76% |
| 2004 FY | 200.93 Thousand CAD | 49.99% |
| 2003 FY | 133.96 Thousand CAD | 107.37% |
| 2003 Q1 | 83.1 Thousand CAD | 28.65% |
| 2003 Q3 | 114.24 Thousand CAD | 18.96% |
| 2003 Q2 | 96.03 Thousand CAD | 15.55% |
| 2003 Q4 | 133.96 Thousand CAD | 17.27% |
| 2002 Q1 | 13.25 Thousand CAD | 0.0% |
| 2002 Q2 | 45.2 Thousand CAD | 241.14% |
| 2002 FY | 64.6 Thousand CAD | 174.07% |
| 2002 Q4 | 64.6 Thousand CAD | 382.49% |
| 2002 Q3 | 13.38 Thousand CAD | -70.38% |
| 2001 FY | 23.57 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 2.11 Million USD | -593.385% |
| Össur hf. | 688.8 Million USD | 97.868% |
| QHSLab, Inc. | 2.05 Million USD | -613.93% |
| Wellstar International, Inc. | 55.99 Million USD | 73.771% |
| Össur hf. | 688.8 Million USD | 97.868% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 2.94 Million USD | -398.107% |
| Aurora Spine Corporation | 6.65 Million USD | -120.723% |
| BrainsWay Ltd. | 15.31 Million USD | 4.101% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| AVITA Medical, Inc. | 19.86 Million USD | 26.073% |
| CVR Medical Corp. | - USD | -Infinity% |
| Hamilton Thorne Ltd. | 45.84 Million USD | 67.965% |
| BioElectronics Corporation | 16.62 Million USD | 11.652% |
| Vivos Inc. | 245 Thousand USD | -5894.147% |
| Kelyniam Global, Inc. | 1.01 Million USD | -1349.836% |
| Zecotek Photonics Inc. | 5.86 Million USD | -150.245% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -5228.43% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | 8.673% |
| Avitar, Inc. | 11.59 Million USD | -26.673% |
| Nanomix Corporation | 14.81 Million USD | 0.87% |
| Theraclion SA | 13.01 Million EUR | -12.825% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -186.599% |
| NewCardio, Inc. | 6.01 Million USD | -144.25% |
| Positron Corporation | 2.02 Million USD | -624.872% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -305.557% |
| Lombard Medical, Inc. | 53.79 Million USD | 72.7% |
| ALR Technologies Inc. | 24.5 Million USD | 40.071% |
| Stratec SE | 271.97 Million USD | 94.6% |
| Vycor Medical, Inc. | 4.31 Million USD | -240.127% |
| Heart Tronics, Inc. | 1.09 Million USD | -1241.436% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -522.604% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 99.409% |
| VMS Rehab Systems, Inc. | 201.36 USD | -7293254.688% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -168.236% |
| Ingen Technologies, Inc. | 5.7 Million USD | -157.217% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -499.471% |
| Odyssey Group International, Inc. | 6.61 Million USD | -122.119% |
| SANUWAVE Health, Inc. | 65.59 Million USD | 77.611% |
| IR-Med Inc. | 634 Thousand USD | -2216.388% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -168.159% |
| United American Healthcare Corporation | 119 Thousand USD | -12241.092% |
| Polarean Imaging plc | 2.58 Million USD | -469.102% |
| ECGI Holdings, Inc. | 11.94 Million USD | -22.994% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -1009.22% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -915.386% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -2067.289% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -172.16% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -73.133% |
| SS Innovations International, Inc. | 11.18 Million USD | -31.346% |
| Urologix, Inc. | 12.64 Million USD | -16.149% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -2695.254% |
| Smith & Nephew plc | 4.76 Billion USD | 99.692% |
| NIOX Group Plc | 9.8 Million USD | -49.824% |
| Fuse Medical, Inc. | 15.11 Million USD | 2.807% |
| Broncus Holding Corporation | 10.43 Million USD | -40.775% |
| Brain Scientific Inc. | 7.42 Million USD | -97.753% |
| Pressure BioSciences, Inc. | 33.8 Million USD | 56.555% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -1749.421% |